|
Opportunities and Challenges in the Adult Attention-Deficit/Hyperactivity Disorder MarketPublished by: Decision Resources Published: Nov. 14, 2005 - 25 Pages The price of this publication has been reduced due to age. The full price was $1,900.Table of Contents
AbstractDrug companies interested in entering the psychiatric market will find significant opportunity in the attention-deficit/hyperactivity disorder (ADHD) market, whose growth is being driven primarily by an increase in the diagnosed, drug-treated adult population. However, drug companies face a major challenge in this market: therapies with novel mechanisms of action are not needed because the currently marketed psychostimulants quickly and effectively alleviate ADHD symptoms.This report provides an overview of adult ADHD, including its prevalence in the major markets that we cover, discussion of current and emerging pharmacological therapies, the factors most likely to drive market growth over 2004-2014, and the challenges that face drug companies seeking to develop therapies for adult ADHD. Finally, we provide an outlook for the adult ADHD market, assessing the potential success of several emerging therapies. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||